Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 188 articles:
HTML format
Text format



Single Articles


    July 2018
  1. THOMPSON JA, Kityo C, Dunn D, Hoppe A, et al
    Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial.
    Clin Infect Dis. 2018 Jul 28. pii: 5060946. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. BEN-DAVID D, Masarwa S, Fallach N, Temkin E, et al
    Success of a National Intervention in Controlling Carbapenem-Resistant Enterobacteriaceae in Israel's Long-Term Care Facilities.
    Clin Infect Dis. 2018 Jul 9. pii: 5050699. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. CHEN XS, Yin YP, Li XY
    A ROADMAP plan to address research needs for gonococcal antimicrobial resistance in China.
    Clin Infect Dis. 2018 Jul 9. pii: 5050687. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  4. RANDOLPH AG, Xu R, Novak T, Newhams MM, et al
    Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children with Influenza-Related Critical Illness.
    Clin Infect Dis. 2018 Jun 9. pii: 5035208. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  5. KLEIN EY, Jiang W, Mojica N, Tseng KK, et al
    National Costs Associated with Methicillin-susceptible and Methicillin-resistant S. aureus Hospitalizations in the United States, 2010-2014.
    Clin Infect Dis. 2018 May 12. pii: 4995458. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. CASSONE M, Mantey J, Perri MB, Gibson K, et al
    Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus Aure and Vancomycin-Resistant Enterococcus Colonization.
    Clin Infect Dis. 2018 May 2. pii: 4991833. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  7. ZAK-DORON Y, Dishon Benattar Y, Pfeffer I, Daikos GL, et al
    The Association between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: A Prospective Study.
    Clin Infect Dis. 2018 Apr 27. pii: 4987600. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. SATLIN MJ, Chavda KD, Baker TM, Chen L, et al
    Colonization with Levofloxacin-Resistant Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
    Clin Infect Dis. 2018 Apr 26. pii: 4986473. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. GUALANDI N, Mu Y, Bamberg WM, Dumyati G, et al
    Racial Disparities in Invasive Methicillin-Resistant Staphylococcus aureus Infections, 2005-2014.
    Clin Infect Dis. 2018 Apr 5. pii: 4961420. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  10. BOJANG A, Camara B, Jagne Cox I, Oluwalana C, et al
    Long-term Impact of Oral Azithromycin taken by Gambian women during Labour on Prevalence and Antibiotic Susceptibility of S. pneumoniae and S. aureus in their Infants: Follow up of a Randomized Clinical Trial.
    Clin Infect Dis. 2018 Mar 28. pii: 4955815. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  11. RAY MJ, Lin MY, Tang AS, Arwady MA, et al
    Regional Spread of an Outbreak of Carbapenem-Resistant Enterobacteriaceae (CRE) through an Ego Network of Healthcare Facilities.
    Clin Infect Dis. 2018 Feb 3. pii: 4836930. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  12. NIGO M, Luce AM, Arias CA
    Long Term Use of Tedizolid as Suppressive Therapy for Recurrent Methicillin-Resistant Staphylococcus aureus Graft Infection.
    Clin Infect Dis. 2018 Jan 23. pii: 4819116. doi: 10.1093.
    PubMed     Text format    


  13. KENYON C
    Risks of antimicrobial resistance in N. gonorrhoeae associated with intensive screening programs in PrEP programs.
    Clin Infect Dis. 2018 Jan 23. pii: 4821305. doi: 10.1093.
    PubMed     Text format    


  14. JENNESS SM, Weiss KM, Goodreau SM, Gift T, et al
    Moving Forward with Treatment of Gonorrhea for Users of HIV Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.
    Clin Infect Dis. 2018 Jan 23. pii: 4821306. doi: 10.1093.
    PubMed     Text format    


  15. NADIMPALLI M, Delarocque-Astagneau E, Love DC, Price LB, et al
    Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries.
    Clin Infect Dis. 2018 Jan 15. pii: 4810441. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. PARENTE DM, Cunha CB, Mylonakis E, Timbrook TT, et al
    The Clinical Utility of Methicillin Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis with Antimicrobial Stewardship Implications.
    Clin Infect Dis. 2018 Jan 11. pii: 4798927. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. GORRIE CL, Mirceta M, Wick RR, Judd LM, et al
    Antimicrobial resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital.
    Clin Infect Dis. 2018 Jan 11. pii: 4798841. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  18. LIN MY, Hayden MK, Lyles RD, Lolans K, et al
    Regional Epidemiology of Methicillin-Resistant Staphylococcus aureus among Adult Intensive Care Unit Patients following State-Mandated Active Surveillance.
    Clin Infect Dis. 2017 Dec 7. pii: 4706267. doi: 10.1093/cid/cix1056.
    PubMed     Text format     Abstract available


  19. WOUDT SHS, de Greeff SC, Schoffelen AF, Vlek ALM, et al
    Antibiotic resistance and the risk of recurrent bacteremia.
    Clin Infect Dis. 2017 Dec 7. pii: 4706269. doi: 10.1093/cid/cix1076.
    PubMed     Text format     Abstract available


    November 2017
  20. HUMPHRIES RM, Hindler JA, Epson E, Horwich-Scholefield S, et al
    Carbapenem-resistant Enterobacteriaceae (CRE) detection practices in California: What are we missing?
    Clin Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  21. HAWKEN SE, Washer LL, Williams CL, Newton DW, et al
    Genomic Investigation of a Putative Endoscope-Associated Carbapenem-Resistant Enterobacter cloacae Outbreak Reveals a Wide Diversity of Circulating Strains and Resistance Mutations.
    Clin Infect Dis. 2017 Oct 26. pii: 4565785. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. TOLEMAN MS, Watkins ER, Williams T, Blane B, et al
    Investigation of a Cluster of Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Transmission in a Community Setting.
    Clin Infect Dis. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. FARHAT MR, Jacobson KR, Franke MF, Kaur D, et al
    Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
    Clin Infect Dis. 2017;65:1364-1370.
    PubMed     Text format     Abstract available


  24. ARDAL C, Rottingen JA, Opalska A, Van Hengel AJ, et al
    Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.
    Clin Infect Dis. 2017;65:1378-1382.
    PubMed     Text format     Abstract available


    September 2017
  25. SCHROEDER MR, Chancey ST, Thomas S, Kuo WH, et al
    A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance
    Clin Infect Dis. 2017;65:990-998.
    PubMed     Text format     Abstract available


  26. GURIEVA T, Dautzenberg MJD, Gniadkowski M, Derde LPG, et al
    The transmissibility of antibiotic-resistant Enterobacteriaceae in Intensive Care Units.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. LEUNG V, Vincent C, Edens T, Miller M, et al
    Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. MILES-JAY A, Weissman SJ, Adler AL, Tchesnokova V, et al
    Epidemiology and antimicrobial resistance characteristics of the ST131-H30 subclone among extraintestinal Escherichia coli collected from US children.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. KATZ AR, Komeya AY, Kirkcaldy RD, Whelen AC, et al
    Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
    Clin Infect Dis. 2017;65:918-923.
    PubMed     Text format     Abstract available


  30. KOSSOW A, Kampmeier S, Willems S, Berdel WE, et al
    Control of Multidrug-Resistant Pseudomonas aeruginosa in Allogeneic Hematopoietic Stem Cell Transplant Recipients by a Novel Bundle Including Remodeling of Sanitary and Water Supply Systems.
    Clin Infect Dis. 2017;65:935-942.
    PubMed     Text format     Abstract available


  31. WOLF J, Tang L, Flynn PM, Pui CH, et al
    Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
    Clin Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. VAN DUIN D, Lok JJ, Earley M, Cober E, et al
    Colistin vs. Ceftazidime-avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2017
  33. KNIGHT GM, Costelloe C, Murray KA, Robotham JV, et al
    Addressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden.
    Clin Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. TASHIRO M, Fushimi K, Kawano K, Takazono T, et al
    Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: A nationwide observational study.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. ABAT C, Rolain JM, Dubourg G, Fournier PE, et al
    Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations.
    Clin Infect Dis. 2017;65.
    PubMed     Text format     Abstract available


  36. MACESIC N, Nelson B, Uhlemann AC
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?
    Clin Infect Dis. 2017;65:702-703.
    PubMed     Text format    


  37. JORDAN MR, Penazzato M, Cournil A, Vubil A, et al
    HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis.
    Clin Infect Dis. 2017 Aug 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. SCHECHTER MC, Bizune D, Kagei M, Machaidze M, et al
    Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.
    Clin Infect Dis. 2017 Aug 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  39. KLEINE CE, Schlabe S, Hischebeth GTR, Molitor E, et al
    Successful therapy of a multi-resistant EBSL (SHV-12)-producing and fluoroquinolone-resistant Salmonella enterica subsp. enterica serovar Typhi infection using combination therapy of meropenem and fosfomycin.
    Clin Infect Dis. 2017 Jul 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. KLEIN EY, Mojica N, Jiang W, Cosgrove SE, et al
    Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. AVERBUCH D, Tridello G, Hoek J, Mikulska M, et al
    Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant patients: intercontinental prospective study of Infectious Diseases Working Party of the European Bone Marrow Transplantation group.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. GEISSLER AL, Bustos Carrillo F, Swanson K, Patrick ME, et al
    Increasing Campylobacter Infections, Outbreaks, and Antimicrobial Resistance in the United States, 2004-2012.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. SCHWABER MJ, Carmeli Y
    The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel.
    Clin Infect Dis. 2017 Jul 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. FABRE V, Cosgrove SE
    A Coordinated and Sustained Response to the Threat of Antibiotic Resistance Is Critical: Lessons Learned From Israel.
    Clin Infect Dis. 2017 Jul 18. doi: 10.1093.
    PubMed     Text format    


    June 2017
  45. JIMENEZ A, Abbo L, Gebrezgi MT
    Importance of carbapenemase production detection in Carbapenem Resistant Enterobacteriaceae. Looking beyond epidemiological purposes.
    Clin Infect Dis. 2017 Jun 16. doi: 10.1093.
    PubMed     Text format    


  46. KOULLIAS Y, Sax PE, Fields NF, Walensky RP, et al
    Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?
    Clin Infect Dis. 2017 Jun 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. LAMOTH F, Chung SJ, Damonti L, Alexander BD, et al
    Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.
    Clin Infect Dis. 2017;64:1619-1621.
    PubMed     Text format     Abstract available


    May 2017
  48. LARSEN J, Petersen A, Larsen AR, Sieber RN, et al
    Emergence of livestock-associated methicillin-resistant Staphylococcus aureus bloodstream infections in Denmark.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. HOOK EW 3RD
    Continued Evolution of Gonococcal Antimicrobial Resistance.
    Clin Infect Dis. 2017 May 26. doi: 10.1093.
    PubMed     Text format    


  50. FELD JJ, Ramji A, Shafran SD, Willems B, et al
    Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study.
    Clin Infect Dis. 2017 May 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. CHO SY, Chung DR
    Infection Prevention Strategy in Hospitals in the Era of Community-Associated Methicillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A Review.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  52. APISARNTHANARAK A, Ratz D, Khawcharoenporn T, Patel PK, et al
    National Survey of Practices to Prevent Methicillin-Resistant Staphylococcus aureus and Multidrug-Resistant Acinetobacter baumannii in Thailand.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  53. MARIMUTHU K, Venkatachalam I, Khong WX, Koh TH, et al
    Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  54. TEERAWATTANAPONG N, Kengkla K, Dilokthornsakul P, Saokaew S, et al
    Prevention and Control of Multidrug-Resistant Gram-Negative Bacteria in Adult Intensive Care Units: A Systematic Review and Network Meta-analysis.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  55. PRUETPONGPUN N, Khawcharoenporn T, Damronglerd P, Suwantarat N, et al
    Inappropriate Empirical Treatment of Uncomplicated Cystitis in Thai Women: Lessons Learned.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  56. TARCHINI G, Liau KH, Solomkin JS
    Antimicrobial Stewardship in Surgery: Challenges and Opportunities.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  57. HONDA H, Ohmagari N, Tokuda Y, Mattar C, et al
    Antimicrobial Stewardship in Inpatient Settings in the Asia Pacific Region: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  58. MANSON AL, Abeel T, Galagan JE, Sundaramurthi JC, et al
    Mycobacterium tuberculosis Whole Genome Sequences From Southern India Suggest Novel Resistance Mechanisms and the Need for Region-Specific Diagnostics.
    Clin Infect Dis. 2017 May 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. SOCIAS ME, Nosova E, Kerr T, Hayashi K, et al
    Patterns of transmitted drug resistance and virological response to first-line antiretroviral treatment among HIV-positive people who use illicit drugs in a Canadian setting.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. GANDRA S, Trett A, Klein EY, Laxminarayan R, et al
    Is Antimicrobial Resistance a Bigger Problem in Tertiary Care Hospitals than in Small Community Hospitals in the United States?
    Clin Infect Dis. 2017 May 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. HEEMSKERK AD, Nguyen MTH, Dang HTM, Vinh Nguyen CV, et al
    Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.
    Clin Infect Dis. 2017 May 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. TOTH DJA, Khader K, Slayton RB, Kallen AJ, et al
    The potential for interventions in a long-term acute care hospital to reduce transmission of carbapenem-resistant Enterobacteriaceae in affiliated healthcare facilities.
    Clin Infect Dis. 2017 May 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  63. RAVEN KE, Gouliouris T, Brodrick H, Coll F, et al
    Complex Routes of Nosocomial Vancomycin-Resistant Enterococcus faecium Transmission Revealed by Genome Sequencing.
    Clin Infect Dis. 2017;64:886-893.
    PubMed     Text format     Abstract available


  64. YANG S, Hemarajata P, Hindler J, Li F, et al
    Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography.
    Clin Infect Dis. 2017;64:894-901.
    PubMed     Text format     Abstract available


  65. TAMMA PD, Rodriguez-Bano J
    The Use of Noncarbapenem beta-Lactams for the Treatment of Extended-Spectrum beta-Lactamase Infections.
    Clin Infect Dis. 2017;64:972-980.
    PubMed     Text format     Abstract available


    March 2017
  66. HEO ST, Tatara AM, Jimenez-Ortigosa C, Jiang Y, et al
    Changes in in vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a tertiary care cancer center (1999-2015).
    Clin Infect Dis. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. BILINSKI J, Grzesiowski P, Sorensen N, Madry K, et al
    Fecal Microbiota Transplantation in Patients with Blood Disorders Inhibits Gut Colonization with Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. WEBB BJ, Healy R, Majers J, Burr Z, et al
    Prediction of Bloodstream Infection due to Vancomycin-Resistant Enterococci in Patients Undergoing Leukemia Induction or Hematopoietic Stem Cell Transplantation.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. VAN HECKE O, Wang K, Lee JJ, Roberts NW, et al
    The implications of antibiotic resistance for patients' recovery from common infections in the community: a systematic review and meta-analysis.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. TSALIK EL, Petzold E, Kreiswirth BN, Bonomo RA, et al
    Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  71. ANDERSON DJ, Jenkins TC, Evans SR, Harris AD, et al
    The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  72. DOI Y, Bonomo RA, Hooper DC, Kaye KS, et al
    Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  73. DOERNBERG SB, Lodise TP, Thaden JT, Munita JM, et al
    Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  74. HUVANE J, Komarow L, Hill C, Tran TT, et al
    Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  75. MANCA C, Hill C, Hujer AM, Patel R, et al
    Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  76. CROSS HR, Harris A, Arias RM, Chambers HF, et al
    Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  77. CHAMBERS HF, Cross HR, Evans SR, Kreiswirth BN, et al
    The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  78. MURRAY BE, Jezek A
    The Antibacterial Resistance Leadership Group: First Steps.
    Clin Infect Dis. 2017;64.
    PubMed     Text format    


  79. MUNITA JM, Aitken SL, Miller WR, Perez F, et al
    Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.
    Clin Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  80. MARKS SM, Mase SR, Bamrah Morris S
    Systematic Review, Meta-Analysis, and Cost Effectiveness of Treatment of Latent Tuberculosis Infection to Reduce Progression to Multidrug-Resistant Tuberculosis.
    Clin Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  81. HEZODE C, Fourati S, Chevaliez S, Scoazec G, et al
    Sofosbuvir-Daclatasvir-Simeprevir plus Ribavirin in Direct-Acting Antiviral-Experienced Hepatitis C Patients.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. HOFSTRA LM, Sanchez Rivas E, Nijhuis M, Bank LE, et al
    High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. COLLINS IJ, Foster C, Tostevin A, Tookey P, et al
    Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. SEE I, Wesson P, Gualandi N, Dumyati G, et al
    Socioeconomic Factors Explain Racial Disparities in Invasive Community-Associated Methicillin-Resistant Staphylococcus aureus Disease Rates.
    Clin Infect Dis. 2017;64:597-604.
    PubMed     Text format     Abstract available


    February 2017
  85. THOMPSOM CN, Karkey A, Dongol S, Ariyal A, et al
    Treatment response in enteric fever in an era of increasing antimicrobial resistance: an individual patient data analysis of 2,092 participants enrolled into four randomised controlled trials in Nepal.
    Clin Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. ONG DS, Frencken JF, Klein Klouwenberg PM, Juffermans N, et al
    Short-course adjunctive gentamicin as empirical therapy in patients with severe sepsis and septic shock: a prospective observational cohort study.
    Clin Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. JOHNSTON JC, Campbell JR, Menzies D
    Effect of intermittency on treatment outcomes in pulmonary tuberculosis: an updated systematic review and meta-analysis.
    Clin Infect Dis. 2017 Feb 14. doi: 10.1093.
    PubMed     Text format    


  88. KIZNY GORDON AE, Mathers AJ, Cheong EY, Gottlieb T, et al
    Is the hospital water environment a reservoir for carbapenem-resistant organisms causing hospital-acquired infections? A systematic review of the literature.
    Clin Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


  89. JACOBSON KR, Barnard M, Kleinman MB, Streicher EM, et al
    Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB/RIF: a multisite observational study.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  90. ROHDE AM, Gastmeier P
    Optimizing Proton Pump Inhibitor Use to Reduce Antimicrobial Resistance Rates?
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


  91. KOH WJ, Jeong BH, Kim SY, Jeon K, et al
    Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Clin Infect Dis. 2017;64:309-316.
    PubMed     Text format     Abstract available


  92. READ TR, Fairley CK, Tabrizi SN, Bissessor M, et al
    Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.
    Clin Infect Dis. 2017;64:250-256.
    PubMed     Text format     Abstract available


  93. PATEL R, Tsalik EL, Petzold E, Fowler VG Jr, et al
    MASTERMIND: Bringing Microbial Diagnostics to the Clinic.
    Clin Infect Dis. 2017;64:355-360.
    PubMed     Text format     Abstract available


  94. MOEHRING RW, Anderson DJ, Cochran RL, Hicks LA, et al
    Expert Consensus on Metrics to Assess the Impact of Patient-Level Antimicrobial Stewardship Interventions in Acute-Care Settings.
    Clin Infect Dis. 2017;64:377-383.
    PubMed     Text format     Abstract available


    January 2017
  95. CHUANG YC, Lin HY, Chen PY, Lin CY, et al
    Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Clin Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2016
  96. HAN JH, Goldstein EJ, Wise J, Bilker WB, et al
    Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals.
    Clin Infect Dis. 2016 Dec 24. pii: ciw856. doi: 10.1093.
    PubMed     Text format     Abstract available


  97. BRITT NS, Potter EM, Patel N, Steed ME, et al
    Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
    Clin Infect Dis. 2016 Dec 22. pii: ciw815. doi: 10.1093.
    PubMed     Text format     Abstract available


  98. ROJAS LJ, Salim M, Cober E, Richter SS, et al
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  99. VINNARD C, King L, Munsiff S, Crossa A, et al
    The Long-Term Mortality of Tuberculosis Meningitis Patients in New York City: A Cohort Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  100. GOMEZ CA, Deresinski S
    Treatment of Hospital or Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Enterobacteriaceae: Leveraging Molecular Resistance Testing and Combination Therapy to Improve Outcomes.
    Clin Infect Dis. 2016;63:1395-1396.
    PubMed     Text format    


  101. TAMMA PD, Goodman KE, Harris AD, Tekle T, et al
    Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Clin Infect Dis. 2016 Nov 9. pii: ciw741. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  102. LOCKHART SR, Etienne KA, Vallabhaneni S, Farooqi J, et al
    Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  103. FETSCH A, Kraushaar B, Kasbohrer A, Hammerl JA, et al
    Turkey Meat as Source of CC9/CC398 Methicillin-Resistant Staphylococcus aureus in Humans?
    Clin Infect Dis. 2016.
    PubMed     Text format    


  104. BROWN L, Langelier C, Reid MJ, Rutishauser RL, et al
    Antimicrobial Resistance: A Call to Action!
    Clin Infect Dis. 2016.
    PubMed     Text format    


    September 2016
  105. TREMBIZKI E, Wand H, Donovan B, Chen M, et al
    The molecular epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Australia: a nationwide cross-sectional study, 2012.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  106. LAVERGNE RA, Chouaki T, Hagen F, Toublanc B, et al
    Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  107. LARSEN J, Stegger M, Andersen PS, Petersen A, et al
    Evidence for Human Adaptation and Foodborne Transmission of Livestock-Associated Methicillin-Resistant Staphylococcus aureus.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  108. SHIELDS RK, Potoski BA, Haidar G, Hao B, et al
    Clinical outcomes, drug toxicity and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  109. SPELLBERG B, Bonomo RA
    Ceftazidime-Avibactam and Carbapenem-Resistant Enterobacteriaceae: "We're Gonna Need a Bigger Boat".
    Clin Infect Dis. 2016.
    PubMed     Text format    


    August 2016
  110. SCIARRETTA K, Rottingen JA, Opalska A, Van-Hengel AJ, et al
    Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations from the Transatlantic Task Force on Antimicrobial Resistance.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  111. GREBELY J, Dore GJ, Zeuzem S, Aspinall RJ, et al
    Efficacy and safety of sofosbuvir/velpatasvir in patients with chronic hepatitis C virus infection receiving opioid substitution therapy: Analysis of Phase 3 ASTRAL trials.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  112. RAY MJ, Lin MY, Weinstein RA, Trick WE, et al
    Spread of Carbapenem-Resistant Enterobacteriaceae Among Illinois Healthcare Facilities: The Role of Patient Sharing.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  113. COLLIGNON PC, Conly JM, Andremont A, McEwen SA, et al
    World Health Organization Ranking of Antimicrobials According to their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance from Food Animal Production.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  114. WU G, Abraham T, Lee S
    Ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae bacteremia.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  115. CHALMERS JD, Reyes LF, Aliberti S, Restrepo MI, et al
    Empirical Coverage of Methicillin-Resistant Staphylococcus aureus in Community-Acquired Pneumonia: Those Who Do Not Remember the Past Are Doomed to Repeat It.
    Clin Infect Dis. 2016.
    PubMed     Text format    


    June 2016
  116. JOUHTEN H, Mattila E, Arkkila P, Satokari R, et al
    Reduction of antibiotic resistance genes in intestinal microbiota of recurrent Clostridium difficile patients after fecal microbiota transplantation.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  117. WALKER E, Lyman A, Gupta K, Mahoney MV, et al
    Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  118. KASSAYE SG, Grossman Z, Balamane M, Johnston-White B, et al
    Transmitted HIV Drug Resistance High and Longstanding in Metropolitan Washington, D.C.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  119. KNISELY JM, Liu B, Ranallo RT, Zou L, et al
    Vaccines for Hospital-Associated Infections: Promise and Challenge.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  120. FATKENHEUER G, Jung N
    Treatment of Asymptomatic Bacteriuria.
    Clin Infect Dis. 2016;62:1190.
    PubMed     Text format    


  121. CAI T, Bartoletti R
    Reply to Fatkenheuer and Jung.
    Clin Infect Dis. 2016;62:1191.
    PubMed     Text format    


    April 2016
  122. KARANIKA S, Kinamon T, Grigoras C, Mylonakis E, et al
    Colonization with Methicillin-Resistant Staphylococcus aureus and Risk for Infection among Asymptomatic Athletes: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  123. DATE KA, Newton AE, Medalla F, Blackstock A, et al
    Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States, 2008-2012.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  124. MANCINI N, Clementi N, Burioni R, Clementi M, et al
    Rational Dosing Strategies of Colistin: What About Resistance?
    Clin Infect Dis. 2016;62:1054.
    PubMed     Text format    


    March 2016
  125. MILLAN B, Park H, Hotte N, Mathieu O, et al
    Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent Clostridium difficile infection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  126. HALPIN AL, McDonald LC
    The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  127. MUNOZ-PRICE LS, Frencken JF, Tarima S, Bonten M, et al
    Handling time dependent variables: antibiotics and antibiotic resistance.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  128. PHILLIPS PP, Morris TP, Walker AS
    DOOR/RADAR: A Gateway Into the Unknown?
    Clin Infect Dis. 2016;62:814-5.
    PubMed     Text format    


  129. EVANS S, Follmann D, Schoenfeld D, Fowler VG Jr, et al
    Reply to Phillips, Morris, and Walker.
    Clin Infect Dis. 2016;62:815-6.
    PubMed     Text format    


  130. IM J, Nichols C, Bjerregaard-Andersen M, Sow AG, et al
    Prevalence of Salmonella Excretion in Stool: A Community Survey in 2 Sites, Guinea-Bissau and Senegal.
    Clin Infect Dis. 2016;62 Suppl 1:S50-5.
    PubMed     Text format     Abstract available


  131. AL-EMRAN HM, Heisig A, Dekker D, Adu-Sarkodie Y, et al
    Detection of a Novel gyrB Mutation Associated With Fluoroquinolone-Nonsusceptible Salmonella enterica serovar Typhimurium Isolated From a Bloodstream Infection in Ghana.
    Clin Infect Dis. 2016;62 Suppl 1:S47-9.
    PubMed     Text format     Abstract available


  132. AL-EMRAN HM, Eibach D, Krumkamp R, Ali M, et al
    A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.
    Clin Infect Dis. 2016;62 Suppl 1:S42-6.
    PubMed     Text format     Abstract available


  133. STEELE AD, Hay Burgess DC, Diaz Z, Carey ME, et al
    Challenges and Opportunities for Typhoid Fever Control: A Call for Coordinated Action.
    Clin Infect Dis. 2016;62 Suppl 1:S4-8.
    PubMed     Text format     Abstract available


  134. EIBACH D, Al-Emran HM, Dekker DM, Krumkamp R, et al
    The Emergence of Reduced Ciprofloxacin Susceptibility in Salmonella enterica Causing Bloodstream Infections in Rural Ghana.
    Clin Infect Dis. 2016;62 Suppl 1:S32-6.
    PubMed     Text format     Abstract available


  135. SEE I, Freifeld AG, Magill SS
    Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated Central Line-Associated Bloodstream Infections from Oncology Settings, 2009-2012.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  136. VAN BAMBEKE F, Tulkens PM
    Editorial Commentary: Colistin and a New Paradigm in Drug Development.
    Clin Infect Dis. 2016;62:559-60.
    PubMed     Text format    


    February 2016
  137. SOLOMKIN JS, Hershberger E, Eckmann C
    Response to Spellberg and Brass.
    Clin Infect Dis. 2016;62:526.
    PubMed     Text format    


  138. SPELLBERG B, Brass EP
    Noninferiority Doesn't Mean Not Inferior.
    Clin Infect Dis. 2016;62:525-6.
    PubMed     Text format    


  139. DETJEN AK, Walters E
    Improving Children's Access to New Tuberculosis Diagnostic Tools Starts With the Collection of Appropriate Specimens.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  140. TOMCZYK SM, Lynfield R, Schaffner W, Reingold A, et al
    Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  141. DENG X, Peirano G, Schillberg E, Mazzulli T, et al
    Whole-Genome Sequencing Reveals the Origin and Rapid Evolution of an Emerging Outbreak Strain of Streptococcus pneumoniae 12F.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  142. FIRNHABER C, Kendall MA, Wu X, Mazurek GH, et al
    Evaluation of Xpert MTB/RIF to identify pulmonary tuberculosis in tuberculosis suspects from low and higher prevalence settings compared to acid fast smear and culture.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  143. FRIPPIAT F, Vercheval C, Layios N
    Decreased Antibiotic Consumption in the Belgian Community: Is It Credible?
    Clin Infect Dis. 2016;62:403-4.
    PubMed     Text format    


    January 2016
  144. IDELEVICH EA, Becker K
    Identification and Susceptibility Testing From Shortly Incubated Cultures Accelerate Blood Culture Diagnostics at No Cost.
    Clin Infect Dis. 2016;62:268-9.
    PubMed     Text format    


  145. BANERJEE R, Teng CB, Cunningham SA, Ihde S, et al
    Reply to Idelevich and Beck.
    Clin Infect Dis. 2016;62:269-70.
    PubMed     Text format    


  146. EVANS SR, Hujer AM, Jiang H, Hujer KM, et al
    Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II.
    Clin Infect Dis. 2016;62:181-9.
    PubMed     Text format     Abstract available


  147. QURESHI AI, Chughtai M, Loua TO, Kolie JP, et al
    Reply to Nanyonga et al.
    Clin Infect Dis. 2016;62:126.
    PubMed     Text format    


  148. OLANS RN, Olans RD, DeMaria A Jr
    The Critical Role of the Staff Nurse in Antimicrobial Stewardship--Unrecognized, but Already There.
    Clin Infect Dis. 2016;62:84-9.
    PubMed     Text format     Abstract available


    December 2015
  149. TABAH A, Cotta MO, Garnacho-Montero J, Schouten J, et al
    A systematic review of the definitions, determinants and clinical outcomes of antimicrobial de-escalation in the intensive care unit.
    Clin Infect Dis. 2015 Dec 23. pii: civ1199.
    PubMed     Text format     Abstract available


  150. LANE CR, Sutton B, Valcanis M, Kirk M, et al
    Travel destinations and sexual behavior as indicators of antibiotic resistant Shigella strains - Victoria, Australia.
    Clin Infect Dis. 2015 Dec 17. pii: civ1018.
    PubMed     Text format     Abstract available


  151. MEITES E, Gaydos CA, Hobbs MM, Kissinger P, et al
    A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Clin Infect Dis. 2015;61 Suppl 8:S837-48.
    PubMed     Text format     Abstract available


  152. HETEM DJ, Bootsma MC, Bonten MJ
    Prevention of surgical site infections: decontamination with mupirocin based on pre-operative screening for Staphylococcus aureus carriers or universal decontamination?
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  153. GHANNOUM M, Roilides E, Katragkou A, Petraitis V, et al
    The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
    Clin Infect Dis. 2015;61 Suppl 6:S618-21.
    PubMed     Text format     Abstract available


  154. PERLIN DS
    Echinocandin Resistance in Candida.
    Clin Infect Dis. 2015;61 Suppl 6:S612-7.
    PubMed     Text format     Abstract available


    November 2015
  155. HOFSTRA LM, Sauvageot N, Albert J, Alexiev I, et al
    Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  156. BUSS BA, Schulz LT, Reed KD, Fox BC, et al
    MALDI-TOF utility in a region with low antibacterial resistance rates.
    Clin Infect Dis. 2015.
    PubMed     Text format    


  157. MILLOY MJ, Wood E, Kerr T, Hogg B, et al
    Increased prevalence of controlled viremia and decreased rates of HIV drug resistance among HIV-positive people who use illicit drugs during a community-wide Treatment-as-Prevention initiative.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  158. MANDOMANDO I, Bassat Q, Sigauque B, Massora S, et al
    Invasive Salmonella Infections Among Children From Rural Mozambique, 2001-2014.
    Clin Infect Dis. 2015;61 Suppl 4:S339-45.
    PubMed     Text format     Abstract available


  159. KARIUKI S, Onsare RS
    Epidemiology and Genomics of Invasive Nontyphoidal Salmonella Infections in Kenya.
    Clin Infect Dis. 2015;61 Suppl 4:S317-24.
    PubMed     Text format     Abstract available


  160. ONEKO M, Kariuki S, Muturi-Kioi V, Otieno K, et al
    Emergence of Community-Acquired, Multidrug-Resistant Invasive Nontyphoidal Salmonella Disease in Rural Western Kenya, 2009-2013.
    Clin Infect Dis. 2015;61 Suppl 4:S310-6.
    PubMed     Text format     Abstract available


  161. MUTHUMBI E, Morpeth SC, Ooko M, Mwanzu A, et al
    Invasive Salmonellosis in Kilifi, Kenya.
    Clin Infect Dis. 2015;61 Suppl 4:S290-301.
    PubMed     Text format     Abstract available


  162. KEDDY KH, Sooka A, Musekiwa A, Smith AM, et al
    Clinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013.
    Clin Infect Dis. 2015;61 Suppl 4:S272-82.
    PubMed     Text format     Abstract available


    October 2015
  163. CEGIELSKI JP, Kurbatova E, van der Walt M, Brand J, et al
    Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment, Initial and Acquired Second-Line Drug Resistance.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  164. VERWEIJ PE, Chowdhary A, Melchers WJ, Meis JF, et al
    Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  165. KNIGHT GM, Colijn C, Shrestha S, Fofana M, et al
    The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.
    Clin Infect Dis. 2015;61Suppl 3:S147-54.
    PubMed     Text format     Abstract available


  166. STARKS AM, Aviles E, Cirillo DM, Denkinger CM, et al
    Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform.
    Clin Infect Dis. 2015;61Suppl 3:S141-6.
    PubMed     Text format     Abstract available


    September 2015
  167. BUTI M, Gordon SC, Zuckerman E, Lawitz E, et al
    Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  168. EVANS SR, Rubin D, Follmann D, Pennello G, et al
    Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR).
    Clin Infect Dis. 2015;61:800-6.
    PubMed     Text format     Abstract available


  169. MOLINA J, Cisneros JM
    Editorial Commentary: A Chance to Change the Paradigm of Outcome Assessment of Antimicrobial Stewardship Programs.
    Clin Infect Dis. 2015;61:807-8.
    PubMed     Text format    


  170. GELFAND MS, Cleveland KO
    Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.
    Clin Infect Dis. 2015;61:853-5.
    PubMed     Text format    


    August 2015
  171. GUMBO T, Pasipanodya JG, Nuermberger E, Romero K, et al
    Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm.
    Clin Infect Dis. 2015;61 Suppl 1:S18-24.
    PubMed     Text format     Abstract available


  172. BOENDER TS, Hoenderboom BM, Sigaloff KC, Hamers RL, et al
    Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


    June 2015
  173. GOTTIG S, Gruber TM, Stecher B, Wichelhaus TA, et al
    In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak.
    Clin Infect Dis. 2015;60:1808-15.
    PubMed     Text format     Abstract available


    May 2015
  174. TONG CY, Costelloe S, Hubb J, Mullen J, et al
    Deep sequencing of HIV-1 in cerebrospinal fluid.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  175. MBISA JL, Fearnhill E, Dunn DT, Pillay D, et al
    Evidence of self-sustaining drug resistant HIV-1 lineages among untreated patients in the UK.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  176. KOUYOS R, Gunthard HF
    The irreversibility of HIV drug resistance.
    Clin Infect Dis. 2015.
    PubMed     Text format    


  177. SOLOMKIN J, Hershberger E, Miller B, Popejoy M, et al
    Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
    Clin Infect Dis. 2015;60:1462-71.
    PubMed     Text format     Abstract available


  178. GAFFIN N
    Reflections from an antimicrobial stewardship program.
    Clin Infect Dis. 2015;60:1588-9.
    PubMed     Text format    


  179. GOLDSTEIN EJ, Tyrrell KL, Citron DM
    Lactobacillus species: taxonomic complexity and controversial susceptibilities.
    Clin Infect Dis. 2015;60 Suppl 2:S98-107.
    PubMed     Text format     Abstract available


  180. LUKAC PJ, Bonomo RA, Logan LK
    Extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat.
    Clin Infect Dis. 2015;60:1389-97.
    PubMed     Text format     Abstract available


    April 2015
  181. WARDYN SE, Forshey BM, Farina SA, Kates AE, et al
    Swine Farming Is a Risk Factor for Infection With and High Prevalence of Carriage of Multidrug-Resistant Staphylococcus aureus.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  182. LISS MA, Johnson JR, Porter SB, Johnston B, et al
    Clinical and microbiological determinants of infection after transrectal prostate biopsy.
    Clin Infect Dis. 2015;60:979-87.
    PubMed     Text format     Abstract available


    March 2015
  183. MADIGAN T, Johnson JR, Clabots C, Johnston BD, et al
    Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-spectrum beta lactamase (ESBL)-producing Escherichia coli sequence type 131 (ST131).
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


    February 2015
  184. DESCAMPS D, Peytavin G, Visseaux B, Tubiana R, et al
    Dolutegravir in HIV-2 infected patients with resistant virus to first-line integrase inhibitors from the French Named Patient Program.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  185. KANTOR R, Smeaton L, Vardhanabhuti S, Hudelson SE, et al
    Pre-Treatment HIV Drug Resistance and HIV-1 Subtype C are Independently Associated with Virologic Failure: Results from the Multi-national PEARLS (ACTG A5175) Clinical Trial.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  186. WAINBERG MA
    The Clinical Significance of HIV Subtype Variability in Regard to Treatment Outcome.
    Clin Infect Dis. 2015.
    PubMed     Text format    


    January 2015
  187. ROGO T, DeLong AK, Chan P, Kantor R, et al
    Antiretroviral Treatment Failure, Drug resistance and Subtype Diversity in the only Pediatric HIV Clinic in Rhode Island.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


    May 2014
  188. WALLIS C, Aga E, Ribaudo H, Saravanan S, et al
    Drug Susceptibility and Resistance Mutations after First-Line Failure in Resource Limited Settings.
    Clin Infect Dis. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: